Insulin aspart, recombinant Subcutaneous and Nefazodone Hydrochloride
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Nefazodone Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: nefazodone
Brand name: Serzone
Synonyms: Nefazodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-NegGram
- Insulin aspart, recombinant Subcutaneous-Nelarabine
- Insulin aspart, recombinant Subcutaneous-Nelarabine Intravenous
- Insulin aspart, recombinant Subcutaneous-Nelfinavir
- Insulin aspart, recombinant Subcutaneous-Nelfinavir Mesylate
- Insulin aspart, recombinant Subcutaneous-Nelfinavir Oral Powder
- Nefazodone Hydrochloride-Insulin degludec
- Nefazodone Hydrochloride-Insulin Degludec (U-100) Prefilled Pens
- Nefazodone Hydrochloride-Insulin Degludec (U-100) Vials
- Nefazodone Hydrochloride-Insulin Degludec (U-200) Prefilled Pens
- Nefazodone Hydrochloride-Insulin degludec and liraglutide
- Nefazodone Hydrochloride-Insulin degludec and liraglutide Subcutaneous